Targeting hyperactivation of the <scp>AKT</scp> survival pathway to overcome therapy resistance of melanoma brain metastasesHeike Niessner, Friedegund Meier|Cancer Medicine|2012Cited by 152
Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated MelanomaHeike Niessner, Tobias Sinnberg|Cancers|2023Cited by 3